Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates

Neurocrine Biosciences Inc (NBIX) reported a profit for its fourth quarter that increased from the same period last year.

The company's earnings came in at $347.9 million, or $3.58 per share. This compares with $34.0 million, or $0.35 per share, in last year's fourth quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $88.1 million or $0.91 per share for the period.

Analysts had expected the company to earn $0.54 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.6% to $247.9 million from $244.1 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q4): $88.1 Mln. vs. $102.2 Mln. last year.
-EPS (Q4): $0.91 vs. $1.05 last year.
-Analysts Estimate: $0.54
-Revenue (Q4): $247.9 Mln vs. $244.1 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT